New Y-90 Data & Evolution Towards Super-Selective Treatment

Pavan Khanna, MD, Chair and Medical Director of the Department of Diagnostic and Interventional Radiology at St. Joseph’s Medical Center in Stockton, California, discusses the evolution of Y-90 for the treatment of hepatocellular carcinoma (HCC). Dr Khanna also reviews the data from the LEGACY and DOSISPHERE trials, which highlight how TheraSphere™ is progressing Y-90 therapy towards more advanced dosimetry techniques and personalization.